Replies to post #176364 on Enzolytics Inc (ENZC)

[I-Glow]

ITV-1 was developed by Immunotech Laboratories.

Regeneron Pharmaceuticals is the only company to do clinical trials in the US. https://clinicaltrials.gov/ct2/show/record/NCT00383370?term=ITV-1&draw=1&rank=1

"Where do you think the ITV-1 therapeutic that is now in Africa treating patients was developed?"

It certainly wasn't Enzolytics or Virogenetics.

Presently, "Our company Immunotech Laboratories BG Ltd. owns the rights for production and distribution of the medicinal product ITV-1 with trading name ImmunH, a drug compound made for the treatment of the HIV-1/AIDS infection....Most importantly, we have successfully completed Phase III for ITV-1 – ImmunH"

"ITV 1
Alternative Names: Immune therapeutic vaccine-1; ImmunH; Inactivated pepsin fraction HIV vaccine; IPF-ITV Phases; IPF-ITV-1; Irreversible pepsin fraction HIV vaccine; ITV-1.

Developer: Immunotech Laboratories

IG